These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6751032)
1. Possible role of dipeptidyl carboxypeptidase n the metabolism of Met5-enkephalin and Met5-enkephalin-Arg6-Phe7. Yang HY; Harsing LG; Majane EM; Costa E Adv Biochem Psychopharmacol; 1982; 33():251-60. PubMed ID: 6751032 [No Abstract] [Full Text] [Related]
2. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception. Chou J; Tang J; Del Rio J; Yang HY; Costa E J Pharmacol Exp Ther; 1984 Aug; 230(2):349-52. PubMed ID: 6205138 [TBL] [Abstract][Full Text] [Related]
3. Substrate- and inhibitor-specificity of a non-endothelial enzyme which forms [Met5]-enkephalin from [Met5]-enkephalin-Arg6,Phe7 in isolated rabbit ear artery: pharmacological characterization. Rónai AZ; Fehér E; Botyánszki J; Hepp J; Magyar A; Medzihradszky K Neuropeptides; 1995 Mar; 28(3):137-45. PubMed ID: 7791957 [TBL] [Abstract][Full Text] [Related]
4. Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors. Zhang AZ; Yang HY; Costa E Neuropharmacology; 1982 Jul; 21(7):625-30. PubMed ID: 6750433 [TBL] [Abstract][Full Text] [Related]
5. Increase of striatal Met5-enkephalin-Arg6-Phe7 (YGGFMRF) content elicited by long-term treatment with haloperidol. Chou J; Tang J; Yang HY; Costa E J Pharmacol Exp Ther; 1984 Apr; 229(1):171-4. PubMed ID: 6368796 [TBL] [Abstract][Full Text] [Related]
6. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens. Blum K; Wallace JE; DeLallo L; Briggs AH Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556 [TBL] [Abstract][Full Text] [Related]
7. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Hiranuma T; Iwao K; Kitamura K; Matsumiya T; Oka T J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain. Norman JA; Autry WL; Barbaz BS Mol Pharmacol; 1985 Dec; 28(6):521-6. PubMed ID: 3001497 [TBL] [Abstract][Full Text] [Related]
9. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia. Reggiani A; Carenzi A; Frigeni V; Della Bella D Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939 [TBL] [Abstract][Full Text] [Related]
10. The effect of peptidase inhibitors on the release of Met5-Enk-Arg6-Phe7 (YGGFMRF) and Met5-enkephalin (YGGFM) from spinal cord induced by substance P in vivo. Tang J; Chou J; Yang HY; Costa E Life Sci; 1983; 33 Suppl 1():121-4. PubMed ID: 6198574 [TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of [Met5]enkephalin semicarbazide is not affected by dipeptidyl carboxypeptidase-I. Rezaee Z; Arabanian SA; Balalaie S; Ahmadiani A; Khalaj L; Nasoohi S J Pept Sci; 2012 Feb; 18(2):92-6. PubMed ID: 22083687 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase. Mellstrom B; Iadarola MJ; Yang HY; Costa E J Pharmacol Exp Ther; 1986 Oct; 239(1):174-8. PubMed ID: 2945003 [TBL] [Abstract][Full Text] [Related]
13. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan. Hiranuma T; Oka T Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition of enkephalins degradation in the nucleus accumbens leads to potentiation of acupuncture and morphine analgesia]. Jin WQ; Zhou ZF; Han JS Sheng Li Xue Bao; 1985 Aug; 37(4):377-82. PubMed ID: 3915599 [No Abstract] [Full Text] [Related]
16. Effect of peptidase inhibitors on [Met5]enkephalin-Arg6-Phe7 and [Met5]enkephalin-Arg6-Gly7-Leu8-induced antinociception. Mellstrom B; Iadarola MJ; Costa E Eur J Pharmacol; 1987 Jan; 133(2):185-90. PubMed ID: 2949992 [TBL] [Abstract][Full Text] [Related]
17. Conversion of [met5]-enkephalin-Arg6-Phe7 to [met5]-enkephalin by dipeptidyl carboxypeptidase. Yang HY; Majane E; Costa E Neuropharmacology; 1981 Sep; 20(9):891-4. PubMed ID: 7027075 [No Abstract] [Full Text] [Related]
18. Estimation of relative importance of three enzymes in the inactivation of [Met5]-enkephalin and [Met5]-enkephalin-Arg6 in three isolated preparations by employing the inhibitor specific for each enzyme. Kuno Y; Oka T Jpn J Pharmacol; 1987 Jul; 44(3):241-7. PubMed ID: 2821306 [TBL] [Abstract][Full Text] [Related]
19. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens. Aoki K; Kajiwara M; Oka T Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948 [TBL] [Abstract][Full Text] [Related]
20. The heptapeptide Met-enkephalin-Arg6, Phe7 is released from rat striatum in vitro by high potassium. Patey G; Cupo A; Giraud P; Chaminade M; Rossier J Neurosci Lett; 1983 Jun; 37(3):267-71. PubMed ID: 6310454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]